Jump to content

4-Methyl-α-methyltryptamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Fswitzer4 (talk | contribs) at 19:10, 6 September 2022 (Added UNII). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

4-Methyl-α-methyltryptamine
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
Identifiers
  • 1-methyl-2-(4-methyl-1H-indol-3-yl)-ethylamine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H16N2
Molar mass188.274 g·mol−1
3D model (JSmol)
  • CC(N)Cc2c1c([nH]c2)cccc1C
  • InChI=1S/C12H16N2/c1-8-4-3-5-11-12(8)10(7-14-11)6-9(2)13/h3-5,7,9,14H,6,13H2,1-2H3 checkY
  • Key:KEOYEGHPRBDSKD-UHFFFAOYSA-N checkY
  (verify)

4-Methyl-αMT (4-Me-αMT), also known as 4,α-dimethyltryptamine (4,α-DMT), and MP-809, is a drug belonging to the tryptamine class that was investigated as an antidepressant in the early 1960s but was never marketed.[1][2]

See also

References

  1. ^ Azima H, Arthurs D, Silver A, Azima FJ (December 1962). "The effect of MP-809 in depressive states: a multi-blind study". The American Journal of Psychiatry. 119 (6): 573–4. doi:10.1176/ajp.119.6.573. PMID 13965759.
  2. ^ Brodey JF, Steiner WG, Himwich HE (April 1963). "An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809)". The Journal of Pharmacology and Experimental Therapeutics. 140: 8–18. PMID 14015664.